Los Angeles Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.2M | Sell |
73,460
-3,095,415
| -98% | -$433M | 0.04% | 252 |
|
|
2025
Q4 | $375M | Sell |
3,168,875
-676,504
| -18% | -$82.2M | 1.28% | 11 |
|
|
2025
Q3 | $427M | Buy |
3,845,379
+1,223,895
| +47% | +$139M | 1.45% | 11 |
|
|
2025
Q2 | $291M | Buy |
2,621,484
+98,448
| +4% | +$10.5M | 1.09% | 15 |
|
|
2025
Q1 | $283M | Buy |
2,523,036
+2,040,261
| +423% | +$211M | 1.25% | 14 |
|
|
2024
Q4 | $44.6M | Buy |
482,775
+65,722
| +16% | +$5.92M | 0.18% | 114 |
|
|
2024
Q3 | $35M | Sell |
417,053
-261,936
| -39% | -$20M | 0.14% | 131 |
|
|
2024
Q2 | $46.6M | Sell |
678,989
-738,365
| -52% | -$49.3M | 0.17% | 113 |
|
|
2024
Q1 | $104M | Sell |
1,417,354
-19,677
| -1% | -$1.51M | 0.35% | 62 |
|
|
2023
Q4 | $116M | Buy |
1,437,031
+501,105
| +54% | +$39M | 0.43% | 55 |
|
|
2023
Q3 | $70.1M | Buy |
935,926
+634,659
| +211% | +$48.8M | 0.3% | 69 |
|
|
2023
Q2 | $23.2M | Sell |
301,267
-228,813
| -43% | -$18.2M | 0.09% | 177 |
|
|
2023
Q1 | $44M | Sell |
530,080
-1,755,157
| -77% | -$145M | 0.2% | 119 |
|
|
2022
Q4 | $196M | Buy |
2,285,237
+155,507
| +7% | +$12.3M | 0.95% | 23 |
|
|
2022
Q3 | $131M | Buy |
2,129,730
+155,376
| +8% | +$9.8M | 0.68% | 31 |
|
|
2022
Q2 | $122M | Sell |
1,974,354
-7,654
| -0.4% | -$474K | 0.6% | 35 |
|
|
2022
Q1 | $118M | Buy |
1,982,008
+752,594
| +61% | +$48.1M | 0.46% | 45 |
|
|
2021
Q4 | $89.3M | Buy |
1,229,414
+641,141
| +109% | +$44.2M | 0.33% | 69 |
|
|
2021
Q3 | $41.1M | Sell |
588,273
-122,198
| -17% | -$8.58M | 0.19% | 110 |
|
|
2021
Q2 | $48.9M | Sell |
710,471
-87,329
| -11% | -$5.83M | 0.22% | 107 |
|
|
2021
Q1 | $51.6M | Buy |
797,800
+320,409
| +67% | +$20.7M | 0.23% | 101 |
|
|
2020
Q4 | $27.8M | Sell |
477,391
-113
| -0% | -$6.82K | 0.12% | 160 |
|
|
2020
Q3 | $30.2M | Buy |
477,504
+84,916
| +22% | +$5.89M | 0.14% | 131 |
|
|
2020
Q2 | $30.2M | Buy |
392,588
+239,647
| +157% | +$18.4M | 0.15% | 149 |
|
|
2020
Q1 | $11.4M | Sell |
152,941
-353,974
| -70% | -$24.5M | 0.07% | 224 |
|
|
2019
Q4 | $32.9M | Buy |
506,915
+88,599
| +21% | +$5.77M | 0.16% | 132 |
|
|
2019
Q3 | $26.5M | Sell |
418,316
-1,627
| -0.4% | -$106K | 0.14% | 146 |
|
|
2019
Q2 | $28.4M | Sell |
419,943
-196,105
| -32% | -$12.9M | 0.15% | 147 |
|
|
2019
Q1 | $40M | Sell |
616,048
-817,276
| -57% | -$54.3M | 0.22% | 110 |
|
|
2018
Q4 | $89.7M | Buy |
1,433,324
+901,998
| +170% | +$63M | 0.56% | 38 |
|
|
2018
Q3 | $41M | Sell |
531,326
-466,330
| -47% | -$35.2M | 0.22% | 119 |
|
|
2018
Q2 | $70.7M | Buy |
997,656
+940,044
| +1,632% | +$66.4M | 0.39% | 43 |
|
|
2018
Q1 | $4.34M | Sell |
57,612
-502,974
| -90% | -$40M | 0.02% | 459 |
|
|
2017
Q4 | $40.2M | Buy |
560,586
+237,987
| +74% | +$18.1M | 0.22% | 124 |
|
|
2017
Q3 | $26.1M | Buy |
322,599
+190,898
| +145% | +$14.6M | 0.15% | 176 |
|
|
2017
Q2 | $9.32M | Sell |
131,701
-2,417,591
| -95% | -$161M | 0.06% | 333 |
|
|
2017
Q1 | $173M | Buy |
2,549,292
+1,092,206
| +75% | +$76.8M | 1.26% | 5 |
|
|
2016
Q4 | $104M | Buy |
1,457,086
+851,028
| +140% | +$63.3M | 0.82% | 18 |
|
|
2016
Q3 | $48M | Buy |
606,058
+577,552
| +2,026% | +$46.9M | 0.4% | 61 |
|
|
2016
Q2 | $2.38M | Sell |
28,506
-1,115,764
| -98% | -$99M | 0.02% | 509 |
|
|
2016
Q1 | $105M | Buy |
1,144,270
+239,856
| +27% | +$21.6M | 0.94% | 18 |
|
|
2015
Q4 | $91.5M | Buy |
904,414
+391,704
| +76% | +$40.8M | 0.84% | 19 |
|
|
2015
Q3 | $50.3M | Buy |
512,710
+177,090
| +53% | +$19.7M | 0.49% | 47 |
|
|
2015
Q2 | $39.3M | Sell |
335,620
-204,566
| -38% | -$22.4M | 0.37% | 77 |
|
|
2015
Q1 | $53M | Sell |
540,186
-480,961
| -47% | -$48.8M | 0.49% | 50 |
|
|
2014
Q4 | $96.3M | Buy |
1,021,147
+183,586
| +22% | +$19M | 0.88% | 20 |
|
|
2014
Q3 | $89.2M | Sell |
837,561
-262,675
| -24% | -$25.7M | 1.08% | 10 |
|
|
2014
Q2 | $91.2M | Buy |
1,100,236
+67,990
| +7% | +$5.29M | 0.88% | 11 |
|
|
2014
Q1 | $73.1M | Buy |
1,032,246
+677,547
| +191% | +$53.1M | 0.8% | 16 |
|
|
2013
Q4 | $26.6M | Sell |
354,699
-435,447
| -55% | -$30.3M | 0.3% | 103 |
|
|
2013
Q3 | $49.7M | Buy |
790,146
+140,616
| +22% | +$8.4M | 0.61% | 29 |
|
|
2013
Q2 | $33.3M | Buy |
+649,530
| New | +$33.9M | 0.47% | 41 |
|
Other funds holding GILD
VCM
VPM
Los Angeles Capital Management's GILD Position: Q1 2026 in Review
Los Angeles Capital Management reduced its Gilead Sciences (GILD) stake by 98% in Q1 2026, selling an estimated $433M and leaving 73,460 shares worth $10.2M. The position accounts for 0.04% of the portfolio, ranked #252.
Los Angeles Capital Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $427M in Q3 2025. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Los Angeles Capital Management held 73,460 shares of Gilead Sciences worth $10.2M as of Q1 2026.
- Los Angeles Capital Management sold 3,095,415 Gilead Sciences shares in Q1 2026, an estimated $433M.
- Gilead Sciences made up 0.04% of Los Angeles Capital Management's portfolio in Q1 2026, its #252 holding.
- Los Angeles Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Los Angeles Capital Management's Gilead Sciences position peaked at $427M in Q3 2025.
- 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.